Biotage´s 2023 Annual Report and Corporate Governance Report are as of today available at: www.biotage.com.

Contacts

Torben Jörgensen, President and CEO

Andrew Kellett, CFO

e: ir@biotage.com

About Biotage

Biotage is the Global Go-To Separations Company, supporting customers from drug discovery and development through to diagnostics and analytical testing with intelligent and sustainable workflow solutions. Our expertise and top-tier separation solutions play a key role in streamlining our customers’ workflows and improving their outcomes.

Headquartered in Sweden, Biotage operates globally with 700 employees, serving over 80 countries. Our company is listed on NASDAQ Stockholm (BIOT).
Website: www.biotage.com

This information is information that Biotage is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, at 2024-04-04 08:00 CEST.

Attachments

CS3 5 ENG Biotage Annual Report 2023
biotageab-2023-12-31-sv

© Modular Finance, source Nordic Press Releases